Study links glucosamine to faster Alzheimer’s progression (opens in new tab)

A University of Florida-led study published June 9 in Nature Metabolism linked glucosamine, an over-the-counter supplement used for joint pain, to faster progression from mild cognitive impairment to Alzheimer’s disease. In anonymized University of Florida Health records, researchers compared 24,000 patients with dementia and 41,000 with mild cognitive impairment and found that glucosamine users with mild cognitive impairment were 25% more likely to progress to Alzheimer’s disease or dementia...